143 related articles for article (PubMed ID: 37254060)
21. CRISPR-DAV: CRISPR NGS data analysis and visualization pipeline.
Wang X; Tilford C; Neuhaus I; Mintier G; Guo Q; Feder JN; Kirov S
Bioinformatics; 2017 Dec; 33(23):3811-3812. PubMed ID: 28961906
[TBL] [Abstract][Full Text] [Related]
22. SSFinder: high throughput CRISPR-Cas target sites prediction tool.
Upadhyay SK; Sharma S
Biomed Res Int; 2014; 2014():742482. PubMed ID: 25089276
[TBL] [Abstract][Full Text] [Related]
23. Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR/Cas systems.
Liu Q; Wang C; Jiao X; Zhang H; Song L; Li Y; Gao C; Wang K
Sci China Life Sci; 2019 Jan; 62(1):1-7. PubMed ID: 30446870
[TBL] [Abstract][Full Text] [Related]
24. Accurate analysis of genuine CRISPR editing events with ampliCan.
Labun K; Guo X; Chavez A; Church G; Gagnon JA; Valen E
Genome Res; 2019 May; 29(5):843-847. PubMed ID: 30850374
[TBL] [Abstract][Full Text] [Related]
25. Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data.
Bloh K; Kanchana R; Bialk P; Banas K; Zhang Z; Yoo BC; Kmiec EB
CRISPR J; 2021 Feb; 4(1):120-131. PubMed ID: 33571043
[TBL] [Abstract][Full Text] [Related]
26. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
Dey A; Nandy S
Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
[TBL] [Abstract][Full Text] [Related]
27. A flexible cross-platform single-cell data processing pipeline.
Battenberg K; Kelly ST; Ras RA; Hetherington NA; Hayashi M; Minoda A
Nat Commun; 2022 Nov; 13(1):6847. PubMed ID: 36369450
[TBL] [Abstract][Full Text] [Related]
28. Web-based design and analysis tools for CRISPR base editing.
Hwang GH; Park J; Lim K; Kim S; Yu J; Yu E; Kim ST; Eils R; Kim JS; Bae S
BMC Bioinformatics; 2018 Dec; 19(1):542. PubMed ID: 30587106
[TBL] [Abstract][Full Text] [Related]
29. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
30. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
Dey A
Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
[TBL] [Abstract][Full Text] [Related]
32. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases.
Zhu LJ; Lawrence M; Gupta A; Pagès H; Kucukural A; Garber M; Wolfe SA
BMC Genomics; 2017 May; 18(1):379. PubMed ID: 28506212
[TBL] [Abstract][Full Text] [Related]
33. Construct design for CRISPR/Cas-based genome editing in plants.
Hassan MM; Zhang Y; Yuan G; De K; Chen JG; Muchero W; Tuskan GA; Qi Y; Yang X
Trends Plant Sci; 2021 Nov; 26(11):1133-1152. PubMed ID: 34340931
[TBL] [Abstract][Full Text] [Related]
34. Technologies and Computational Analysis Strategies for CRISPR Applications.
Clement K; Hsu JY; Canver MC; Joung JK; Pinello L
Mol Cell; 2020 Jul; 79(1):11-29. PubMed ID: 32619467
[TBL] [Abstract][Full Text] [Related]
35. Highly Multiplexed Analysis of CRISPR Genome Editing Outcomes in Mammalian Cells.
Ishiguro S; Yachie N
Methods Mol Biol; 2021; 2312():193-223. PubMed ID: 34228292
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
37. AddTag, a two-step approach with supporting software package that facilitates CRISPR/Cas-mediated precision genome editing.
Seher TD; Nguyen N; Ramos D; Bapat P; Nobile CJ; Sindi SS; Hernday AD
G3 (Bethesda); 2021 Sep; 11(9):. PubMed ID: 34544122
[TBL] [Abstract][Full Text] [Related]
38. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
Xu Z; Li Y; Li M; Xiang H; Yan A
Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing.
Çerçi B; Uzay IA; Kara MK; Dinçer P
Life Sci; 2023 Jan; 312():121204. PubMed ID: 36403643
[TBL] [Abstract][Full Text] [Related]
40. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
Li X; Shi W; Geng LZ; Xu JP
Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
